We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
+2.75%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$95.4B
AUM Growth
–
Cap. Flow
+$95.1B
Cap. Flow
% of AUM
99.75%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,598
New
3,563
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.01B |
| 2 |
JPMorgan Chase
JPM
|
+$1.9B |
| 3 |
Chevron
CVX
|
+$1.68B |
| 4 |
Wells Fargo
WFC
|
+$1.46B |
| 5 |
GE Aerospace
GE
|
+$1.37B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.05% |
| 2 | Healthcare | 14.97% |
| 3 | Energy | 11.28% |
| 4 | Industrials | 10.05% |
| 5 | Technology | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Northern Trust
NTRS
$22.2B
| $46.8M | 0.05% |
+808,690
| New | +$45.2M |
|
|
FON
327
DELISTED
SPRINT CORP FON COM
FON
| $46.7M | 0.05% |
+6,653,235
| New | +$46.7M |
|
328
Acadia Pharmaceuticals
ACAD
$4.25B
| $46.2M | 0.05% |
+2,542,909
| New | +$35M |
|
329
Eastman Chemical
EMN
$7.8B
| $46.1M | 0.05% |
+658,699
| New | +$45.9M |
|
|
EQC
330
DELISTED
Equity Commonwealth
EQC
| $45.6M | 0.05% |
+1,973,444
| New | +$42.6M |
|
|
ENDP
331
DELISTED
Endo International plc
ENDP
| $45.4M | 0.05% |
+1,234,107
| New | +$44.4M |
|
|
ACH
332
Accendra Health
ACH
$240M
| $44.7M | 0.05% |
+1,321,572
| New | +$43.9M |
|
333
Genuine Parts
GPC
$17.1B
| $44.7M | 0.05% |
+571,943
| New | +$44.4M |
|
334
Revvity
RVTY
$12.3B
| $44.6M | 0.05% |
+1,373,142
| New | +$44.9M |
|
335
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $44.5M | 0.05% |
+277,600
| New | +$44.7M |
|
|
MWE
336
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $44.5M | 0.05% |
+665,706
| New | +$42.8M |
|
337
Icon
ICLR
$12.8B
| $44.1M | 0.05% |
+1,245,295
| New | +$41M |
|
338
BHP
BHP
$213B
| $44.1M | 0.05% |
+904,864
| New | +$50.2M |
|
339
Myriad Genetics
MYGN
$530M
| $43.4M | 0.05% |
+1,616,543
| New | +$46.9M |
|
340
Telefônica Brasil
VIV
$22.4B
| $43.3M | 0.05% |
+1,897,260
| New | +$48.4M |
|
|
SWN
341
DELISTED
Southwestern Energy Company
SWN
| $43.2M | 0.05% |
+1,182,955
| New | +$43.9M |
|
342
Mettler-Toledo International
MTD
$26.8B
| $42.7M | 0.04% |
+212,024
| New | +$45.2M |
|
343
Encompass Health
EHC
$11.2B
| $42.1M | 0.04% |
+1,837,456
| New | +$41.5M |
|
344
Ionis Pharmaceuticals
IONS
$9.35B
| $41.2M | 0.04% |
+1,534,031
| New | +$32.6M |
|
|
IPG
345
DELISTED
Interpublic Group of Companies
IPG
| $41.1M | 0.04% |
+2,824,190
| New | +$39.8M |
|
|
PPL.PRW
346
DELISTED
PPL CORP CORP UITS CONSISTING OF PUR CONTRACT JR SUB NTS
PPL.PRW
| $40.9M | 0.04% |
+755,476
| New | +$41.7M |
|
347
RenaissanceRe
RNR
$13.7B
| $40.7M | 0.04% |
+469,450
| New | +$41.6M |
|
348
Williams-Sonoma
WSM
$26.7B
| $40.4M | 0.04% |
+1,444,730
| New | +$38.9M |
|
349
HF Sinclair
DINO
$15.9B
| $40.1M | 0.04% |
+938,014
| New | +$44.8M |
|
350
Veeco
VECO
$3.15B
| $40.1M | 0.04% |
+1,131,986
| New | +$42.6M |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for BlackRock Advisors, which disclosed 3,598 positions worth $95.4B. Its ten largest holdings account for 15% of the portfolio.
Its largest position is Pfizer: 72,772,651 shares worth $1.93B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, followed by Healthcare and Energy.
- BlackRock Advisors's largest Q2 2013 buy was Pfizer: 72,772,651 shares worth $1.93B.
- BlackRock Advisors's ten largest holdings make up 15% of its $95.4B portfolio in Q2 2013.
- BlackRock Advisors disclosed 3,598 positions in Q2 2013, its first 13F filing on record.
Based on BlackRock Advisors's 13F filing for Q2 2013, filed 13 Aug 2013.